Multifunctional Mycobacterial Topoisomerases with Distinctive Features

Area of Science:

• Microbiology
• Biochemistry
• Drug Discovery

Background:

• Tuberculosis (TB) remains a significant global health threat, exacerbated by multidrug-resistant (MDR-TB) and extensively drug-resistant (XDR-TB) strains.
• Mycobacterium tuberculosis exhibits remarkable adaptability, complicating treatment and necessitating novel therapeutic strategies.
• DNA topoisomerases are crucial enzymes for managing DNA topology during cellular processes and represent validated targets for antibacterial drug development.

Purpose of the Study:

• To review the organization, structure, function, and regulation of DNA gyrase and Topoisomerase I (TopoI) in Mycobacterium tuberculosis.
• To explore the potential of these enzymes as targets for developing new anti-TB therapeutics.
• To provide insights into existing and emerging inhibitors of mycobacterial topoisomerases.

Main Methods:

• Comparative analysis of mycobacterial DNA gyrase and TopoI structures and biochemical properties against counterparts from other bacteria.
• Review of established DNA gyrase inhibitors and novel bacterial topoisomerase inhibitors (NBTIs).
• Update on TopoI-specific compounds, with a focus on those targeting mycobacteria.

Main Results:

• DNA topoisomerases in M. tuberculosis possess unique characteristics compared to other bacterial species.
• These enzymes are essential for pathogen survival, highlighting their potential as drug targets.
• A range of inhibitors targeting DNA gyrase and TopoI exist, with ongoing development of novel agents.

Conclusions:

• Targeting DNA topoisomerases in Mycobacterium tuberculosis offers a promising avenue for developing new drugs against drug-resistant TB.
• Understanding the specific properties of mycobacterial topoisomerases is key to designing effective and selective inhibitors.
• Further research into novel bacterial topoisomerase inhibitors (NBTIs) and TopoI-specific compounds is warranted for combating TB.